The pathway enrichment analyses, particularly on the upregulated DEGs in T-SCLC (Fig. 1A and B), highlighted genes such as PPM1E, INSM1, DPYSL5, KCNC1, CPLX2, and others. This evidence concerns the gene CPLX2 and small cell lung carcinoma.